FNY Managed Accounts’s Raptor Pharmaceutical RPTP Stock Holding History
Bought
Maintained
Sold
FNY Managed Accounts's RPTP Position: Q4 2016 in Review
FNY Managed Accounts sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 12,423 shares — an estimated $111K sold.
FNY Managed Accounts first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $111K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- FNY Managed Accounts reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
- FNY Managed Accounts sold 12,423 Raptor Pharmaceutical shares in Q4 2016, an estimated $111K.
- FNY Managed Accounts first reported a position in Raptor Pharmaceutical in Q3 2016 and held it in 1 quarter.
- FNY Managed Accounts's Raptor Pharmaceutical position peaked at $111K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.
Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.